تقرير تحليل حجم السوق العالمية لميكروبيوم الجلد، وحصتها السوقية، واتجاهاتها - نظرة عامة على الصناعة وتوقعاتها حتى عام 2032

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL SKIN MICROBIOME MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE GLOBAL SKIN MICROBIOME MARKET SIZE

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 TRIPOD DATA VALIDATION MODEL

2.2.4 MARKET GUIDE

2.2.5 MULTIVARIATE MODELLING

2.2.6 TOP TO BOTTOM ANALYSIS

2.2.7 CHALLENGE MATRIX

2.2.8 APPLICATION COVERAGE GRID

2.2.9 STANDARDS OF MEASUREMENT

2.2.10 EPIDEMIOLOGY BASED MODEL

2.2.11 VENDOR SHARE ANALYSIS

2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 GLOBAL SKIN MICROBIOME MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

5.1 REGULATORY SCENARIO

5.2 PESTEL ANALYSIS

5.3 PORTER’S 5 FORCES

5.4 REIMBURSMENT SCENARIO

6 INDUSTRY INSIGHTS

7 REGULATORY FRAMEWORK

8 GLOBAL SKIN MICROBIOME MARKET, BY PRODUCT

9 NOTE: MARKET VALUE, VOLUME AND ASP ANALYSIS WOULD BE PROVIDED FOR ALL SEGMENTS AND SUB-SEGMENTS OF PRODUCT)

9.1 OVERVIEW

9.2 PROBIOTIC

9.2.1 LACTOCOCCUS

9.2.1.1. TOPICAL

9.2.1.1.1. SPRAY

9.2.1.1.1.1 MARKET VALUE(USD MILLION)

9.2.1.1.1.2 MARKET VOLUME(UNITS)

9.2.1.1.1.3 AVERAGE SELLING PRICE(ASP)

9.2.1.1.2. SERUM

9.2.1.1.2.1 MARKET VALUE(USD MILLION)

9.2.1.1.2.2 MARKET VOLUME(UNITS)

9.2.1.1.2.3 AVERAGE SELLING PRICE(ASP)

9.2.1.1.3. MOISTURIZER

9.2.1.1.3.1 MARKET VALUE(USD MILLION)

9.2.1.1.3.2 MARKET VOLUME(UNITS)

9.2.1.1.3.3 AVERAGE SELLING PRICE(ASP)

9.2.1.1.4. OIL

9.2.1.1.4.1 MARKET VALUE(USD MILLION)

9.2.1.1.4.2 MARKET VOLUME(UNITS)

9.2.1.1.4.3 AVERAGE SELLING PRICE(ASP)

9.2.1.1.5. CLEANSER

9.2.1.1.5.1 MARKET VALUE(USD MILLION)

9.2.1.1.5.2 MARKET VOLUME(UNITS)

9.2.1.1.5.3 AVERAGE SELLING PRICE(ASP)

9.2.1.1.6. GELS

9.2.1.1.6.1 MARKET VALUE(USD MILLION)

9.2.1.1.6.2 MARKET VOLUME(UNITS)

9.2.1.1.6.3 AVERAGE SELLING PRICE(ASP)

9.2.1.1.7. MASKS

9.2.1.1.7.1 MARKET VALUE(USD MILLION)

9.2.1.1.7.2 MARKET VOLUME(UNITS)

9.2.1.1.7.3 AVERAGE SELLING PRICE(ASP)

9.2.1.1.8. PRIMERS

9.2.1.1.8.1 MARKET VALUE(USD MILLION)

9.2.1.1.8.2 MARKET VOLUME(UNITS)

9.2.1.1.8.3 AVERAGE SELLING PRICE(ASP)

9.2.1.1.9. OTHERS

9.2.1.2. ORAL

9.2.1.3. OTHERS

9.2.2 BIFIDOBACTERIUM

9.2.2.1. TOPICAL

9.2.2.1.1. SPRAY

9.2.2.1.1.1 MARKET VALUE(USD MILLION)

9.2.2.1.1.2 MARKET VOLUME(UNITS)

9.2.2.1.1.3 AVERAGE SELLING PRICE(ASP)

9.2.2.1.2. SERUM

9.2.2.1.2.1 MARKET VALUE(USD MILLION)

9.2.2.1.2.2 MARKET VOLUME(UNITS)

9.2.2.1.2.3 AVERAGE SELLING PRICE(ASP)

9.2.2.1.3. MOISTURIZER

9.2.2.1.3.1 MARKET VALUE(USD MILLION)

9.2.2.1.3.2 MARKET VOLUME(UNITS)

9.2.2.1.3.3 AVERAGE SELLING PRICE(ASP)

9.2.2.1.4. OIL

9.2.2.1.4.1 MARKET VALUE(USD MILLION)

9.2.2.1.4.2 MARKET VOLUME(UNITS)

9.2.2.1.4.3 AVERAGE SELLING PRICE(ASP)

9.2.2.1.5. CLEANSER

9.2.2.1.5.1 MARKET VALUE(USD MILLION)

9.2.2.1.5.2 MARKET VOLUME(UNITS)

9.2.2.1.5.3 AVERAGE SELLING PRICE(ASP)

9.2.2.1.6. GELS

9.2.2.1.6.1 MARKET VALUE(USD MILLION)

9.2.2.1.6.2 MARKET VOLUME(UNITS)

9.2.2.1.6.3 AVERAGE SELLING PRICE(ASP)

9.2.2.1.7. MASKS

9.2.2.1.7.1 MARKET VALUE(USD MILLION)

9.2.2.1.7.2 MARKET VOLUME(UNITS)

9.2.2.1.7.3 AVERAGE SELLING PRICE(ASP)

9.2.2.1.8. PRIMERS

9.2.2.1.8.1 MARKET VALUE(USD MILLION)

9.2.2.1.8.2 MARKET VOLUME(UNITS)

9.2.2.1.8.3 AVERAGE SELLING PRICE(ASP)

9.2.2.1.9. OTHERS

9.2.2.2. ORAL

9.2.2.3. OTHERS

9.2.3 STREPTOCOCCUS THERMOPHILUS

9.2.3.1. TOPICAL

9.2.3.1.1. SPRAY

9.2.3.1.1.1 MARKET VALUE(USD MILLION)

9.2.3.1.1.2 MARKET VOLUME(UNITS)

9.2.3.1.1.3 AVERAGE SELLING PRICE(ASP)

9.2.3.1.2. SERUM

9.2.3.1.2.1 MARKET VALUE(USD MILLION)

9.2.3.1.2.2 MARKET VOLUME(UNITS)

9.2.3.1.2.3 AVERAGE SELLING PRICE(ASP)

9.2.3.1.3. MOISTURIZER

9.2.3.1.3.1 MARKET VALUE(USD MILLION)

9.2.3.1.3.2 MARKET VOLUME(UNITS)

9.2.3.1.3.3 AVERAGE SELLING PRICE(ASP)

9.2.3.1.4. OIL

9.2.3.1.4.1 MARKET VALUE(USD MILLION)

9.2.3.1.4.2 MARKET VOLUME(UNITS)

9.2.3.1.4.3 AVERAGE SELLING PRICE(ASP)

9.2.3.1.5. CLEANSER

9.2.3.1.5.1 MARKET VALUE(USD MILLION)

9.2.3.1.5.2 MARKET VOLUME(UNITS)

9.2.3.1.5.3 AVERAGE SELLING PRICE(ASP)

9.2.3.1.6. GELS

9.2.3.1.6.1 MARKET VALUE(USD MILLION)

9.2.3.1.6.2 MARKET VOLUME(UNITS)

9.2.3.1.6.3 AVERAGE SELLING PRICE(ASP)

9.2.3.1.7. MASKS

9.2.3.1.7.1 MARKET VALUE(USD MILLION)

9.2.3.1.7.2 MARKET VOLUME(UNITS)

9.2.3.1.7.3 AVERAGE SELLING PRICE(ASP)

9.2.3.1.8. PRIMERS

9.2.3.1.8.1 MARKET VALUE(USD MILLION)

9.2.3.1.8.2 MARKET VOLUME(UNITS)

9.2.3.1.8.3 AVERAGE SELLING PRICE(ASP)

9.2.3.1.9. OTHERS

9.2.3.2. ORAL

9.2.3.3. OTHERS

9.2.4 SACCHAROMYCES

9.2.4.1. TOPICAL

9.2.4.1.1. SPRAY

9.2.4.1.1.1 MARKET VALUE(USD MILLION)

9.2.4.1.1.2 MARKET VOLUME(UNITS)

9.2.4.1.1.3 AVERAGE SELLING PRICE(ASP)

9.2.4.1.2. SERUM

9.2.4.1.2.1 MARKET VALUE(USD MILLION)

9.2.4.1.2.2 MARKET VOLUME(UNITS)

9.2.4.1.2.3 AVERAGE SELLING PRICE(ASP)

9.2.4.1.3. MOISTURIZER

9.2.4.1.3.1 MARKET VALUE(USD MILLION)

9.2.4.1.3.2 MARKET VOLUME(UNITS)

9.2.4.1.3.3 AVERAGE SELLING PRICE(ASP)

9.2.4.1.4. OIL

9.2.4.1.4.1 MARKET VALUE(USD MILLION)

9.2.4.1.4.2 MARKET VOLUME(UNITS)

9.2.4.1.4.3 AVERAGE SELLING PRICE(ASP)

9.2.4.1.5. CLEANSER

9.2.4.1.5.1 MARKET VALUE(USD MILLION)

9.2.4.1.5.2 MARKET VOLUME(UNITS)

9.2.4.1.5.3 AVERAGE SELLING PRICE(ASP)

9.2.4.1.6. GELS

9.2.4.1.6.1 MARKET VALUE(USD MILLION)

9.2.4.1.6.2 MARKET VOLUME(UNITS)

9.2.4.1.6.3 AVERAGE SELLING PRICE(ASP)

9.2.4.1.7. MASKS

9.2.4.1.7.1 MARKET VALUE(USD MILLION)

9.2.4.1.7.2 MARKET VOLUME(UNITS)

9.2.4.1.7.3 AVERAGE SELLING PRICE(ASP)

9.2.4.1.8. PRIMERS

9.2.4.1.8.1 MARKET VALUE(USD MILLION)

9.2.4.1.8.2 MARKET VOLUME(UNITS)

9.2.4.1.8.3 AVERAGE SELLING PRICE(ASP)

9.2.4.1.9. OTHERS

9.2.4.2. ORAL

9.2.4.3. OTHERS

9.2.5 LACTOBACILLUS

9.2.5.1. TOPICAL

9.2.5.1.1. SPRAY

9.2.5.1.1.1 MARKET VALUE(USD MILLION)

9.2.5.1.1.2 MARKET VOLUME(UNITS)

9.2.5.1.1.3 AVERAGE SELLING PRICE(ASP)

9.2.5.1.2. SERUM

9.2.5.1.2.1 MARKET VALUE(USD MILLION)

9.2.5.1.2.2 MARKET VOLUME(UNITS)

9.2.5.1.2.3 AVERAGE SELLING PRICE(ASP)

9.2.5.1.3. MOISTURIZER

9.2.5.1.3.1 MARKET VALUE(USD MILLION)

9.2.5.1.3.2 MARKET VOLUME(UNITS)

9.2.5.1.3.3 AVERAGE SELLING PRICE(ASP)

9.2.5.1.4. OIL

9.2.5.1.4.1 MARKET VALUE(USD MILLION)

9.2.5.1.4.2 MARKET VOLUME(UNITS)

9.2.5.1.4.3 AVERAGE SELLING PRICE(ASP)

9.2.5.1.5. CLEANSER

9.2.5.1.5.1 MARKET VALUE(USD MILLION)

9.2.5.1.5.2 MARKET VOLUME(UNITS)

9.2.5.1.5.3 AVERAGE SELLING PRICE(ASP)

9.2.5.1.6. GELS

9.2.5.1.6.1 MARKET VALUE(USD MILLION)

9.2.5.1.6.2 MARKET VOLUME(UNITS)

9.2.5.1.6.3 AVERAGE SELLING PRICE(ASP)

9.2.5.1.7. MASKS

9.2.5.1.7.1 MARKET VALUE(USD MILLION)

9.2.5.1.7.2 MARKET VOLUME(UNITS)

9.2.5.1.7.3 AVERAGE SELLING PRICE(ASP)

9.2.5.1.8. PRIMERS

9.2.5.1.8.1 MARKET VALUE(USD MILLION)

9.2.5.1.8.2 MARKET VOLUME(UNITS)

9.2.5.1.8.3 AVERAGE SELLING PRICE(ASP)

9.2.5.1.9. OTHERS

9.2.5.2. ORAL

9.2.5.3. OTHERS

9.2.6 LEUCONOSTOC

9.2.6.1. TOPICAL

9.2.6.1.1. SPRAY

9.2.6.1.1.1 MARKET VALUE(USD MILLION)

9.2.6.1.1.2 MARKET VOLUME(UNITS)

9.2.6.1.1.3 AVERAGE SELLING PRICE(ASP)

9.2.6.1.2. SERUM

9.2.6.1.2.1 MARKET VALUE(USD MILLION)

9.2.6.1.2.2 MARKET VOLUME(UNITS)

9.2.6.1.2.3 AVERAGE SELLING PRICE(ASP)

9.2.6.1.3. MOISTURIZER

9.2.6.1.3.1 MARKET VALUE(USD MILLION)

9.2.6.1.3.2 MARKET VOLUME(UNITS)

9.2.6.1.3.3 AVERAGE SELLING PRICE(ASP)

9.2.6.1.4. OIL

9.2.6.1.4.1 MARKET VALUE(USD MILLION)

9.2.6.1.4.2 MARKET VOLUME(UNITS)

9.2.6.1.4.3 AVERAGE SELLING PRICE(ASP)

9.2.6.1.5. CLEANSER

9.2.6.1.5.1 MARKET VALUE(USD MILLION)

9.2.6.1.5.2 MARKET VOLUME(UNITS)

9.2.6.1.5.3 AVERAGE SELLING PRICE(ASP)

9.2.6.1.6. GELS

9.2.6.1.6.1 MARKET VALUE(USD MILLION)

9.2.6.1.6.2 MARKET VOLUME(UNITS)

9.2.6.1.6.3 AVERAGE SELLING PRICE(ASP)

9.2.6.1.7. MASKS

9.2.6.1.7.1 MARKET VALUE(USD MILLION)

9.2.6.1.7.2 MARKET VOLUME(UNITS)

9.2.6.1.7.3 AVERAGE SELLING PRICE(ASP)

9.2.6.1.8. PRIMERS

9.2.6.1.8.1 MARKET VALUE(USD MILLION)

9.2.6.1.8.2 MARKET VOLUME(UNITS)

9.2.6.1.8.3 AVERAGE SELLING PRICE(ASP)

9.2.6.1.9. OTHERS

9.2.6.2. ORAL

9.2.6.3. OTHERS

9.3 PREBIOTIC

9.3.1 PLANT BASED

9.3.2 SYNTHESIZED

9.4 OTHERS

10 GLOBAL SKIN MICROBIOME MARKET, BY TYPES

10.1 OVERVIEW

10.2 RESIDENT MICROORGANISMS

10.3 TRANSIENT BACTERIA

11 GLOBAL SKIN MICROBIOME MARKET, BY DISEASE

11.1 OVERVIEW

11.2 ATOPIC DERMATITIS

11.3 ACNE VULGARIS

11.4 ROSACEA

11.5 PSORIASIS VULGARIS

11.6 ATOPIC DERMATITIS

11.7 PEMPHIGUS

11.8 ALOPECIA AREATA

11.9 EPIDERMOLYSIS BULLOSA

11.1 SCLERODERMA

11.11 ICHTHYOSIS

11.12 VITILIGO

11.13 OTHERS

12 GLOBAL SKIN MICROBIOME MARKET, BY ROUTE OF ADMINISTRATION

12.1 OVERVIEW

12.2 TOPICAL

12.3 ORAL

13 GLOBAL SKIN MICROBIOME MARKET, BY SKIN TYPE

13.1 OVERVIEW

13.2 MOIST SKIN

13.2.1 TOPICAL

13.2.2 ORAL

13.3 DRY SKIN

13.3.1 TOPICAL

13.3.2 ORAL

13.4 OILY SKIN

13.4.1 TOPICAL

13.4.2 ORAL

13.5 OTHER

14 GLOBAL SKIN MICROBIOME MARKET, BY POPULATION TYPE

14.1 OVERVIEW

14.2 MEN

14.3 WOMEN

14.4 CHILDREN

15 GLOBAL SKIN MICROBIOME MARKET, BY END USER

15.1 OVERVIEW

15.2 HOSPITALS

15.3 DERMATOLOGY HOSPITAL

15.4 SPECILITY HOSPITALS

15.5 SPA OR SALON

15.6 BEAUTY PARLERS

15.7 HOME HEALTHCARE

15.8 OTHERS

16 GLOBAL SKIN MICROBIOME MARKET, BY DISTRIBUTION CHANNEL

16.1 OVERVIEW

16.2 HOSPITAL PHARMACIES

16.3 RETAIL SALES

16.3.1 DRUG STORE

16.3.2 COMPANY OWNED BRANDED STORE

16.3.3 MULTIBRANDED STORE

16.3.4 OTHER

16.4 ONLINE SALES

16.4.1 COMPANY OWNED WEBSITE

16.4.2 E- COMMERCE WEBSITES

16.4.3 ONLINE PHARMACY

16.5 OTHER

17 GLOBAL SKIN MICROBIOME MARKET, COMPANY LANDSCAPE

17.1 COMPANY SHARE ANALYSIS: GLOBAL

17.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

17.3 COMPANY SHARE ANALYSIS: EUROPE

17.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

17.5 MERGERS & ACQUISITIONS

17.6 NEW PRODUCT DEVELOPMENT & APPROVALS

17.7 EXPANSIONS

17.8 REGULATORY CHANGES

17.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

17.1

18 GLOBAL SKIN MICROBIOME MARKET, BY COUNTRY

GLOBAL SKIN MICROBIOME MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

18.1 NORTH AMERICA

18.1.1 U.S.

18.1.2 CANADA

18.1.3 MEXICO

18.2 EUROPE

18.2.1 GERMANY

18.2.2 U.K.

18.2.3 ITALY

18.2.4 FRANCE

18.2.5 SPAIN

18.2.6 RUSSIA

18.2.7 SWITZERLAND

18.2.8 TURKEY

18.2.9 BELGIUM

18.2.10 NETHERLANDS

18.2.11 DENMARK

18.2.12 SWEDEN

18.2.13 POLAND

18.2.14 NORWAY

18.2.15 FINLAND

18.2.16 REST OF EUROPE

18.3 ASIA-PACIFIC

18.3.1 JAPAN

18.3.2 CHINA

18.3.3 SOUTH KOREA

18.3.4 INDIA

18.3.5 SINGAPORE

18.3.6 THAILAND

18.3.7 INDONESIA

18.3.8 MALAYSIA

18.3.9 PHILIPPINES

18.3.10 AUSTRALIA

18.3.11 NEW ZEALAND

18.3.12 VIETNAM

18.3.13 TAIWAN

18.3.14 REST OF ASIA-PACIFIC

18.4 SOUTH AMERICA

18.4.1 BRAZIL

18.4.2 ARGENTINA

18.4.3 REST OF SOUTH AMERICA

18.5 MIDDLE EAST AND AFRICA

18.5.1 SOUTH AFRICA

18.5.2 EGYPT

18.5.3 BAHRAIN

18.5.4 UNITED ARAB EMIRATES

18.5.5 KUWAIT

18.5.6 OMAN

18.5.7 QATAR

18.5.8 SAUDI ARABIA

18.5.9 REST OF MEA

18.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

19 GLOBAL SKIN MICROBIOME MARKET, SWOT AND DBMR ANALYSIS

20 GLOBAL SKIN MICROBIOME MARKET, COMPANY PROFILE

20.1 AURELIA LONDON

20.1.1 COMPANY OVERVIEW

20.1.2 REVENUE ANALYSIS

20.1.3 GEOGRAPHIC PRESENCE

20.1.4 PRODUCT PORTFOLIO

20.1.5 RECENT DEVELOPMENTS

20.2 GALLINÉE.

20.2.1 COMPANY OVERVIEW

20.2.2 REVENUE ANALYSIS

20.2.3 GEOGRAPHIC PRESENCE

20.2.4 PRODUCT PORTFOLIO

20.2.5 RECENT DEVELOPMENTS

20.3 DAKOTA BIOTECH

20.3.1 COMPANY OVERVIEW

20.3.2 REVENUE ANALYSIS

20.3.3 GEOGRAPHIC PRESENCE

20.3.4 PRODUCT PORTFOLIO

20.3.5 RECENT DEVELOPMENTS

20.4 MOTHER DIRT'S

20.4.1 COMPANY OVERVIEW

20.4.2 REVENUE ANALYSIS

20.4.3 GEOGRAPHIC PRESENCE

20.4.4 PRODUCT PORTFOLIO

20.4.5 RECENT DEVELOPMENTS

20.5 ESSE SKINCARE

20.5.1 COMPANY OVERVIEW

20.5.2 REVENUE ANALYSIS

20.5.3 GEOGRAPHIC PRESENCE

20.5.4 PRODUCT PORTFOLIO

20.5.5 RECENT DEVELOPMENTS

20.6 S-BIOMEDIC

20.6.1 COMPANY OVERVIEW

20.6.2 REVENUE ANALYSIS

20.6.3 GEOGRAPHIC PRESENCE

20.6.4 PRODUCT PORTFOLIO

20.6.5 RECENT DEVELOPMENTS

20.7 ELIZABETH ARDEN

20.7.1 COMPANY OVERVIEW

20.7.2 REVENUE ANALYSIS

20.7.3 GEOGRAPHIC PRESENCE

20.7.4 PRODUCT PORTFOLIO

20.7.5 RECENT DEVELOPMENTS

20.8 YUN PEROBIOTHERAPY

20.8.1 COMPANY OVERVIEW

20.8.2 REVENUE ANALYSIS

20.8.3 GEOGRAPHIC PRESENCE

20.8.4 PRODUCT PORTFOLIO

20.8.5 RECENT DEVELOPMENTS

20.9 TULA LIFE, INC

20.9.1 COMPANY OVERVIEW

20.9.2 REVENUE ANALYSIS

20.9.3 GEOGRAPHIC PRESENCE

20.9.4 PRODUCT PORTFOLIO

20.9.5 RECENT DEVELOPMENTS

20.1 THE BEAUTY CHEF.

20.10.1 COMPANY OVERVIEW

20.10.2 REVENUE ANALYSIS

20.10.3 GEOGRAPHIC PRESENCE

20.10.4 PRODUCT PORTFOLIO

20.10.5 RECENT DEVELOPMENTS

20.11 L’OREAL PARIS

20.11.1 COMPANY OVERVIEW

20.11.2 REVENUE ANALYSIS

20.11.3 GEOGRAPHIC PRESENCE

20.11.4 PRODUCT PORTFOLIO

20.11.5 RECENT DEVELOPMENTS

20.12 CLINIQUE LABORATORIES, LLC.

20.12.1 COMPANY OVERVIEW

20.12.2 REVENUE ANALYSIS

20.12.3 GEOGRAPHIC PRESENCE

20.12.4 PRODUCT PORTFOLIO

20.12.5 RECENT DEVELOPMENTS

20.13 LA ROCHE-POSAY

20.13.1 COMPANY OVERVIEW

20.13.2 REVENUE ANALYSIS

20.13.3 GEOGRAPHIC PRESENCE

20.13.4 PRODUCT PORTFOLIO

20.13.5 RECENT DEVELOPMENTS

20.14 BEBE & BELLA, LLC.

20.14.1 COMPANY OVERVIEW

20.14.2 REVENUE ANALYSIS

20.14.3 GEOGRAPHIC PRESENCE

20.14.4 PRODUCT PORTFOLIO

20.14.5 RECENT DEVELOPMENTS

20.15 AMOREPACIFIC,

20.15.1 COMPANY OVERVIEW

20.15.2 REVENUE ANALYSIS

20.15.3 GEOGRAPHIC PRESENCE

20.15.4 PRODUCT PORTFOLIO

20.15.5 RECENT DEVELOPMENTS

20.16 BELANO MEDICAL AG

20.16.1 COMPANY OVERVIEW

20.16.2 REVENUE ANALYSIS

20.16.3 GEOGRAPHIC PRESENCE

20.16.4 PRODUCT PORTFOLIO

20.16.5 RECENT DEVELOPMENTS

20.17 GLOWBIOTICS LLC

20.17.1 COMPANY OVERVIEW

20.17.2 REVENUE ANALYSIS

20.17.3 GEOGRAPHIC PRESENCE

20.17.4 PRODUCT PORTFOLIO

20.17.5 RECENT DEVELOPMENTS

20.18 AOBIOME

20.18.1 COMPANY OVERVIEW

20.18.2 REVENUE ANALYSIS

20.18.3 GEOGRAPHIC PRESENCE

20.18.4 PRODUCT PORTFOLIO

20.18.5 RECENT DEVELOPMENTS

20.19 LAFLORE

20.19.1 COMPANY OVERVIEW

20.19.2 REVENUE ANALYSIS

20.19.3 GEOGRAPHIC PRESENCE

20.19.4 PRODUCT PORTFOLIO

20.19.5 RECENT DEVELOPMENTS

20.2 ESTÉE LAUDER INC

20.20.1 COMPANY OVERVIEW

20.20.2 REVENUE ANALYSIS

20.20.3 GEOGRAPHIC PRESENCE

20.20.4 PRODUCT PORTFOLIO

20.20.5 RECENT DEVELOPMENTS

20.21 ALGENIST

20.21.1 COMPANY OVERVIEW

20.21.2 REVENUE ANALYSIS

20.21.3 GEOGRAPHIC PRESENCE

20.21.4 PRODUCT PORTFOLIO

20.21.5 RECENT DEVELOPMENTS

20.22 BEBE & BELLA

20.22.1 COMPANY OVERVIEW

20.22.2 REVENUE ANALYSIS

20.22.3 GEOGRAPHIC PRESENCE

20.22.4 PRODUCT PORTFOLIO

20.22.5 RECENT DEVELOPMENTS

20.23 DSM

20.23.1 COMPANY OVERVIEW

20.23.2 REVENUE ANALYSIS

20.23.3 GEOGRAPHIC PRESENCE

20.23.4 PRODUCT PORTFOLIO

20.23.5 RECENT DEVELOPMENTS

20.24 EMINENCE ORGANIC SKIN CARE

20.24.1 COMPANY OVERVIEW

20.24.2 REVENUE ANALYSIS

20.24.3 GEOGRAPHIC PRESENCE

20.24.4 PRODUCT PORTFOLIO

20.24.5 RECENT DEVELOPMENTS

20.25 BIOPHILE

20.25.1 COMPANY OVERVIEW

20.25.2 REVENUE ANALYSIS

20.25.3 GEOGRAPHIC PRESENCE

20.25.4 PRODUCT PORTFOLIO

20.25.5 RECENT DEVELOPMENTS

20.26 PIERRE FABRE GROUP

20.26.1 COMPANY OVERVIEW

20.26.2 REVENUE ANALYSIS

20.26.3 GEOGRAPHIC PRESENCE

20.26.4 PRODUCT PORTFOLIO

20.26.5 RECENT DEVELOPMENTS

20.27 SIOLTA THERAPEUTICS

20.27.1 COMPANY OVERVIEW

20.27.2 REVENUE ANALYSIS

20.27.3 GEOGRAPHIC PRESENCE

20.27.4 PRODUCT PORTFOLIO

20.27.5 RECENT DEVELOPMENTS

20.28 IORA INDIA

20.28.1 COMPANY OVERVIEW

20.28.2 REVENUE ANALYSIS

20.28.3 GEOGRAPHIC PRESENCE

20.28.4 PRODUCT PORTFOLIO

20.28.5 RECENT DEVELOPMENTS

20.29 PROTA SKINCARE

20.29.1 COMPANY OVERVIEW

20.29.2 REVENUE ANALYSIS

20.29.3 GEOGRAPHIC PRESENCE

20.29.4 PRODUCT PORTFOLIO

20.29.5 RECENT DEVELOPMENTS

20.3 SABINSA.

20.30.1 COMPANY OVERVIEW

20.30.2 REVENUE ANALYSIS

20.30.3 GEOGRAPHIC PRESENCE

20.30.4 PRODUCT PORTFOLIO

20.30.5 RECENT DEVELOPMENTS

NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST

21 RELATED REPORTS

22 CONCLUSION

23 QUESTIONNAIRE

24 ABOUT DATA BRIDGE MARKET RESEARCH